Literature DB >> 22525027

Detection of extracellular genomic DNA scaffold in human thrombus: implications for the use of deoxyribonuclease enzymes in thrombolysis.

Rahmi Oklu1, Hassan Albadawi, Michael T Watkins, Marc Monestier, Martin Sillesen, Stephan Wicky.   

Abstract

PURPOSE: Mechanisms underlying transition of a thrombus susceptible to tissue plasminogen activator (TPA) fibrinolysis to one that is resistant is unclear. Demonstration of a new possible thrombus scaffold may open new avenues of research in thrombolysis and may provide mechanistic insight into thrombus remodeling.
MATERIALS AND METHODS: Ten human thrombus samples were collected during cases of thrombectomy and open surgical repair of abdominal aortic aneurysms (five samples < 3 d old and five samples > 1 y old). Additionally, an acute murine hindlimb ischemia model was created to evaluate thrombus samples in mice. Human sections were immunostained for the H2A/H2B/DNA complex, myeloperoxidase, fibrinogen, and von Willebrand factor. Mouse sections were immunostained with the H2A antibody. All samples were further evaluated after hematoxylin and eosin and Masson trichrome staining.
RESULTS: An extensive network of extracellular histone/DNA complex was demonstrated in the matrix of human ex vivo thrombus. This network is present throughout the highly cellular acute thrombus. However, in chronic thrombi, detection of the histone/DNA network was predominantly in regions of low collagen content and high cell density, which were mostly near the lumen. These regions of high cell density contained neutrophils and monocytes. Similarly, sections from the acute murine hindlimb ischemia model also exhibited extensive immunoreactivity to the histone antibody in the extracellular space within murine thrombi.
CONCLUSIONS: Extensive detection of genomic DNA associated with histones in the extracellular matrix of human and mouse thrombi suggest the presence of a new thrombus-associated scaffold.
Copyright © 2012 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22525027     DOI: 10.1016/j.jvir.2012.01.072

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  23 in total

1.  Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cells.

Authors:  F Semeraro; C T Ammollo; N L Esmon; C T Esmon
Journal:  J Thromb Haemost       Date:  2014-08-26       Impact factor: 5.824

Review 2.  Neutrophils: back in the thrombosis spotlight.

Authors:  Denis F Noubouossie; Brandi N Reeves; Brian D Strahl; Nigel S Key
Journal:  Blood       Date:  2019-03-21       Impact factor: 22.113

Review 3.  Hemostasis and nanotechnology.

Authors:  Patrick Hangge; Jonathan Stone; Hassan Albadawi; Yu Shrike Zhang; Ali Khademhosseini; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 4.  Anti-fouling strategies for central venous catheters.

Authors:  Alex Wallace; Hassan Albadawi; Nikasha Patel; Ali Khademhosseini; Yu Shrike Zhang; Sailendra Naidu; Grace Knuttinen; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 5.  Deep vein thrombosis: pathogenesis, diagnosis, and medical management.

Authors:  Jonathan Stone; Patrick Hangge; Hassan Albadawi; Alex Wallace; Fadi Shamoun; M Grace Knuttien; Sailendra Naidu; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 6.  Bioengineered in vitro models of thrombosis: methods and techniques.

Authors:  Yu Shrike Zhang; Rahmi Oklu; Hassan Albadawi
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 7.  Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations.

Authors:  Drew Fleck; Hassan Albadawi; Fadi Shamoun; Grace Knuttinen; Sailendra Naidu; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 8.  Thrombosis in cancer patients: etiology, incidence, and management.

Authors:  Rahul A Sheth; Andrew Niekamp; Keith B Quencer; Fadi Shamoun; Martha-Gracia Knuttinen; Sailendra Naidu; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 9.  Can thrombus age guide thrombolytic therapy?

Authors:  Christopher Czaplicki; Hassan Albadawi; Sasan Partovi; Ripal T Gandhi; Keith Quencer; Amy R Deipolyi; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 10.  Thrombosis: tangled up in NETs.

Authors:  Kimberly Martinod; Denisa D Wagner
Journal:  Blood       Date:  2013-12-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.